Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07226583 · ClinicalTrials.gov registry record · NA
Using a Personalized Decision Support Tool to Help People With Type 1 Diabetes Manage Exercise
A NA study, sponsored by Stanford University.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07226583: Clinical Trial NA study, sponsored by Stanford University.
NCT07226583 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07226583, a NA study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study evaluates a clinician-facing decision-support toolkit designed to assist adults with type 1 diabetes in preparing for moderate-intensity exercise. The netIOB \& Exercise Toolkit (NEXT) integrates recent glucose data and insulin delivery history to provide individualized suggestions regarding exercise timing, insulin adjustments, and carbohydrate intake. Adults with type 1 diabetes will complete three supervised exercise sessions under different pre-exercise guidance approaches: (A) published consensus-based standard-of-care guidance, (B) usual personal care routines, and (C) guidance informed by the NEXT Toolkit. A healthy adult control group will complete a single supervised exercise session to provide comparative physiologic data.
Primary Outcome
This composite outcome reflects glycemic risk during exercise and the subsequent post-exercise monitoring period. The score is based on a Magni risk-derived metric computed from continuous glucose monitoring (CGM) data, with the glycemic effects of rescue carbohydrate treatments removed to isolate underlying glycemic risk. Each evaluated timepoint is given a score ranging from 0 to 100, where lower scores indicate lower glycemic risk and higher scores indicate higher glycemic risk. Scores acro
Interventions
- DEVICE Continuous Glucose Monitoring
- BEHAVIORAL Usual Care (UC)
- BEHAVIORAL Standard-of-Care Guidance (SoC)
- DEVICE netIOB & Exercise Toolkit (NEXT)
- DEVICE Continuous Ketone Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-04 |
| Est. Completion | 2026-08 |
| Phase | NA |
What is known before NCT07226583 opens enrollment
NCT07226583 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Continuous Glucose Monitoring is the first listed.
NCT07226583 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07226583 about?
NCT07226583 is a clinical study titled "Using a Personalized Decision Support Tool to Help People With Type 1 Diabetes Manage Exercise". This study evaluates a clinician-facing decision-support toolkit designed to assist adults with type 1 diabetes in preparing for moderate-intensity exercise. The netIOB \& Exercise Toolkit (NEXT) integrates recent glucose data and insulin delivery history to provide individualized suggestions regard...
What is the current status of trial NCT07226583?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-04. Estimated completion is 2026-08.
What interventions are being tested in trial NCT07226583?
The interventions under investigation include: Continuous Glucose Monitoring (DEVICE), Usual Care (UC) (BEHAVIORAL), Standard-of-Care Guidance (SoC) (BEHAVIORAL), netIOB & Exercise Toolkit (NEXT) (DEVICE), Continuous Ketone Monitoring (DEVICE).
Who is sponsoring clinical trial NCT07226583?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07226583's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia